Antigen Information
General Information of This Antigen
| Antigen ID | TAR0AWPXW |
|||||
|---|---|---|---|---|---|---|
| Antigen Name | T-cell surface glycoprotein CD3 (CD3) |
|||||
| Gene Name | CD3 |
|||||
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
BCN-B12 B12-v1a-145
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
EP4090377A1 B12-v1a-145-PF01
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
EP4090377A1 B12-v1a-145-PF08
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
BCN-PEG11-BCN (105)
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BCN-PEG11-IL15 (PF20)
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
BCN-rituximab rit-v1a-145
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a-145-204
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF01
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF02
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF03
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF08
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF09
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF17
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-145-PF19
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
BCN-Rituximab Rit-v1a-145
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a-145-PF13
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
bis-azido-rituximab rit-v1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a- (201)2
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a-PF23
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a- (PF07)2
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
|
|
Rit-v1a- (PF20)2
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
bis-azido-Rituximab rit-v1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a- (PF15)2
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
bis-azido-Rituximab Rit-v1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a-145-PF27
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
bis-azido-rituximab Rit-v1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a-PF29
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
rit-v3
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v3- (PF15)2
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
rituximab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
BCN-rituximab rit-v1a-145
[1]
|
Undisclosed |
Undisclosed |
linker145 |
rituximab rit-v1a
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
TCO-rituximab rit-v1a-XL11
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |
TCO-rituximab rit-v1a-XL11
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Rit-v1a-XL11-204
[1]
|
Undisclosed |
Undisclosed |
Undisclosed |